Director, Field Medical - WestUnited States

About the role

The Opportunity We’re looking for a Director of Field Medical to serve as the regional scientific lead during a pivotal stage of our growth. This senior, full-scope Medical Science Liaison role rests on two pillars: leading high-level scientific exchange and key opinion leader relationships across your region and serving as the field-facing scientific partner to Maze's clinical development programs. It’s a genuine scientific leadership position, not site support with a scientific veneer. With MZE829 entering its pivotal program in 2027 and MZE782 advancing through Phase 2, your immediate priority is enabling the clinical programs, so trial and investigator support carries real weight from day one. Because Maze is genetics-first, you’ll need credibility across two distinct communities: nephrology (AMKD, FSGS, CKD) and metabolic disease (PKU). Initially, an individual contributor, you’ll build the region's scientific relationships and support trial execution, then help recruit, mentor, and eventually lead a regional MSL team as we grow.

Responsibilities

• Scientific Exchange & KOL Engagement: You’ll be a recognized scientific expert and the trusted face of Maze in your regions. Lead compliant, peer-to-peer scientific exchange with thought leaders, physicians, renal pathologists, and PKU specialists, and build a durable regional KOL map, including in a metabolic community where Maze isn’t yet known. Provide accurate scientific education on AMKD, FSGS, CKD, and PKU, including APOL1 biology and SLC6A19 substrate reduction, and respond to unsolicited medical inquires. Represent Maze at major congresses (ASN, NKF, and metabolic/PKU societies) and support advisory boards, scientific meetings, and patient advocacy partnerships.
• Clinical Development & Investigator Partnerships: The immediate priority. You’ll be the field-facing scientific partner accountable for site engagement and scientific barriers affecting enrollment across your region. Serve as the regional scientific partner to Maze's trials, including HORIZON and the MZE829, and MZE782, and the single point of contact for investigators and sites. Shape site selection through feasibility input, and support site identification, investigator meetings, and start-up. Own the field-side response to enrollment and retention barriers, driving compliant scientific solutions with Clinical Operations.
• Genetic Testing & Patient Identification: Support adoption of APOL1 genotyping and advance genotype-driven patient identification pathways, the mechanism by which eligible patients reach the trials. Address the trust and access barriers facing an AMKD population disproportionately of African ancestry, a concrete enrollment lever, not a peripheral consideration.
• Medical Insights & Strategic Input: Capture field insight (treatment patterns, unmet need, evidence gaps, competitive intelligence) on a consistent cadence, and translate it into recommendations that shape medical strategy